The Wistar Institute Receives Two Biomedical Research Grants from the V Foundation for Cancer Research
Notified -
Globe Newswire16-12-2024, 23:03
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss 28-08-2025, 19:30